Cerebral Toxoplasmosis and AIDS
NCT00803621 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 46
Last updated 2019-07-05
Summary
With a HIV incidence much higher in the DFA than in European French territory, this disease is a major public health problem in these areas, especially in French Guiana.
Cerebral toxoplasmosis is a priority among the opportunistic infections in AIDS patients from the DFA because of its frequency (French West Indies) and of its lethality (French Guiana).
The diagnosis of cerebral toxoplasmosis may be difficult because based only on presumptive clinical and radiological features. The response to specific antitoxoplasmic therapy confirms a posteriori the diagnosis.
In reference to the data collected by the Biological Resource Centre Toxoplasma, in particular in French Guiana, we think that T. gondii strains reactivating in AIDS patients from DFA are genetically different from those reactivating in AIDS patients from Europe, with an increased capacity for dissemination via peripheral blood in the first ones. This more frequent or more prolonged parasitemia could facilitate the diagnosis of cerebral toxoplasmosis by PCR test from peripheral blood samples in AIDS patients from the French departments of America.
Conditions
- Cerebral Toxoplasmosis
- AIDS
Interventions
- OTHER
-
Toxoplasma PCR assay
Toxoplasma PCR assay
Sponsors & Collaborators
-
University Hospital, Limoges
lead OTHER
Principal Investigators
-
Daniel AJZENBERG, PharmD, PhD · CHU Limoges
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-06-30
- Primary Completion
- 2012-12-31
- Completion
- 2013-12-31
Countries
- France
Study Locations
More Related Trials
-
Measuring the Prevalence of Toxoplasmosis and Its Socio-economic Consequences
NCT05860998 ·Status: UNKNOWN
-
Diagnosis of Toxoplasma Gondii Infection by Exploration of Cellular Immunity (TOXCELL)
NCT04825600 ·Status: COMPLETED ·Phase: NA
-
Neurological Consequences of Perinatal Listeriosis Infection
NCT02580812 ·Status: COMPLETED ·Phase: NA
-
Safe Pregnancy by Infectious Disease Control
NCT00489619 ·Status: COMPLETED
-
Study of Decreasing Kinetics of the Leptospiremia During Antibiotic Treatment of Leptospirosis in Martinique
NCT02000635 ·Status: UNKNOWN
-
Seropositivity and Adverse Birth Events in Migrants From Bilharzia-endemic Areas
NCT03158298 ·Status: TERMINATED
-
New Diagnostic Approach for Congenital Toxoplasmosis
NCT03385499 ·Status: UNKNOWN ·Phase: NA
-
Acute Infectious Encephalitis and Myelitis in Guadeloupe by New Generation Sequencing
NCT07251049 ·Status: RECRUITING
-
Treatment of Cerebral Toxoplasmosis in HIV/AIDS
NCT00367081 ·Status: COMPLETED ·Phase: PHASE4
-
STD Screening in Women Admitted in Family Planning for a Termination of Pregnancy
NCT03486522 ·Status: UNKNOWN
-
Evaluation of Biological Biomarkers Diagnostic of Toxoplasmosis Uveitis
NCT02843438 ·Status: COMPLETED ·Phase: NA
-
Etiology of Orphan Community-based Meningitis and Meningo-encephalitis.
NCT02868593 ·Status: UNKNOWN ·Phase: NA
-
Prevention of Congenital Toxoplasmosis With Pyrimethamine + Sulfadiazine Versus Spiramycine During Pregnancy
NCT01189448 ·Status: COMPLETED ·Phase: PHASE3
-
Immune Response After Leptospirosis Infection
NCT02898519 ·Status: UNKNOWN
-
Prevention of Diseases Induced by Chlamydia Trachomatis
NCT02904811 ·Status: COMPLETED ·Phase: NA
-
Rapid Molecular Diagnosis and Detection of Emerging Infectious Diseases in Patients With Tropical Fever (Tropifever)
NCT06539325 ·Status: RECRUITING ·Phase: NA
-
Preventing Congenital Syphilis
NCT02353117 ·Status: COMPLETED ·Phase: NA
-
Reducing Acquisition of CMV Through Antenatal Education
NCT03511274 ·Status: COMPLETED ·Phase: NA
-
Severe Group A Streptococcus Infections in Paris, France, 2018-2023
NCT06297122 ·Status: COMPLETED
-
Prognostic Value of Neonatal Markers for the Development of Neurosensorial Sequelae in Children Infected by Cytomegalovirus in Utero
NCT01923636 ·Status: COMPLETED ·Phase: NA
-
RT-PCR SARS-CoV-2 at 1 Month of COVID-19 Infection in the Geriatric Population
NCT04427358 ·Status: COMPLETED
-
Genetic Susceptibility to Severe Streptococcal Infections
NCT01911572 ·Status: UNKNOWN
-
Optimizing the Diagnosis of Pneumocystis in Immunocompromised Patients
NCT06890078 ·Status: RECRUITING
-
Estimated Cumulative Incidence of Zika Infection at the End of the First Epidemic in the French West Indies in a Sample of Patients Followed for HIV Infection.
NCT03161444 ·Status: TERMINATED ·Phase: NA
-
Prospective, Monocentric, Interventional Study on Spontaneous Vaginal Clearance of Mycoplasma Genitalium
NCT04841408 ·Status: COMPLETED ·Phase: NA